Characterizing variability in fluorescence-based forensic DNA measurement and developing an electrochemical-based quantification system by Rowan, Kayleigh
Boston University
OpenBU http://open.bu.edu
Theses & Dissertations Boston University Theses & Dissertations
2014
Characterizing variability in
fluorescence-based forensic DNA
measurement and developing an
electrochemical-based
quantification system
https://hdl.handle.net/2144/14658
Boston University
BOSTON UNIVERSITY 
 
SCHOOL OF MEDICINE 
 
 
 
 
Thesis 
 
 
 
 
CHARACTERIZING VARIABILITY IN FLUORESCENCE-BASED FORENSIC 
DNA MEASUREMENT AND DEVELOPING AN ELECTROCHEMICAL-BASED 
QUANTIFICATION SYSTEM  
 
by 
 
KAYLEIGH ELIZABETH ROWAN 
 
B.S., Northeastern University, 2012 
 
 
 
 
 
 
Submitted in partial fulfillment of the 
 
requirements for the degree of 
 
Master of Science 
 
2014 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2014 
KAYLEIGH ELIZABETH ROWAN 
All rights reserved  
Approved by 
 
 
 
 
 
 
 
 
 
First Reader   
  
 Catherine Grgicak, Ph.D. 
 Assistant Professor of Biomedical Forensic Sciences 
 
 
 
 
 
 
 
 
 
Second Reader   
  
 Desmond Lun, Ph.D. 
 Associate Professor and Chair, Department of Computer 
Science 
 Rutgers University 
 
 
 
 
 
iv 
 
Acknowledgements 
I would like to thank Dr. Grgicak for her support and guidance throughout 
my research and the writing process. I would also like to thank Desmond Lun and 
Kelly Brockhohn for serving on my thesis committee.  
Additionally, the dynamic model presented in this work was possible 
through the guidance of Dr. Kevin Hallock and Dr. Kip Thomas. I would also like 
to thank Kevin Hu and Lauren Alfonse for their help in running the simulated 
experiments using the model.  
Lastly, I would like to thank my family and friends for their continuous 
support over the past two years.  
 
 
 
 
 
 
 
v 
 
CHARACTERIZING VARIABILITY IN FLUORESCENCE-BASED FORENSIC 
DNA MEASUREMENT AND DEVELOPING AN ELECTROCHEMICAL-BASED 
QUANTIFICATION SYSTEM 
KAYLEIGH ELIZABETH ROWAN 
 
Abstract 
A reliable and robust laboratory method is essential for the forensic 
analysis of deoxyribonucleic acid (DNA), particularly for low-template samples. 
Electropherogram peak heights are important to the identification of STR alleles, 
and these peak heights are prone to error. Since error can be introduced into the 
process during sample preparation, quantification, amplification, or analysis, 
validation studies are performed in an attempt to characterize the signal variation 
associated with the process. While current practices assess aspects of a method, 
such as sensitivity and reproducibility, the effects of daily laboratory alterations 
are often not considered. Additionally, samples used in a validation study may be 
prepared using serial dilutions. Therefore, understanding the extent to which 
error is propagated through the series and the effect it has on the results could 
help improve validation practices.  
 This work aimed to assess the effect daily laboratory modifications have 
on the signal in a forensic electropherogram. Specifically, the variability in signal 
when different capillary and amplification kit lots were used was evaluated 
against the variability observed when a single sample was either injected or 
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amplified multiple times. The variability was determined via the examination of 
peak heights, peak height ratios, stutter, and drop-out. The effect of serially 
diluting samples was examined via an in silico model of the dilution process, 
polymerase chain reaction (PCR), and capillary injection. The peak heights from 
simulated serially diluted samples using the concentration of a stock DNA were 
compared to the peak heights from simulated samples that were quantified after 
the dilution series was generated and prior to amplification.   
 The different capillary lots and amplifications were found to result in 
greater variation compared to the multiple injections. Additionally, when the 
stutter percentages obtained from using multiple kit lots were compared to those 
obtained using the same kit lot, differences in stutter percentage deviations 
resulted in different stutter thresholds. Drop-out rates were also different between 
the samples amplified with one kit versus the same samples amplified with 
multiple kit lots. Therefore, at a minimum, multiple amplifications should be run 
on multiple capillary lots during validation. Further, if available, the use of multiple 
kit lots is recommended, particularly in cases where stutter thresholds or drop-out 
models are used during interpretation. Creating validation samples via serial 
dilutions was also found to increase the variation observed in peak height in the 
simulated samples, suggesting that samples should be quantified post-dilution.   
In addition to characterizing the variability of several components of DNA 
analysis, an alternative quantification method was investigated in order to 
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decrease the overall variability associated with the quantification process. This 
work sought to develop an electrochemical biosensor using a single-stranded 
DNA (ssDNA) probe chemically adsorbed to a gold electrode. This would allow 
for the direct quantification of DNA and eliminate the need for qPCR and 
fluorescent-based oligonucleotide detection systems. The DNA probe was 
successfully adsorbed to the surface of the gold disk electrode, hybridized to a 
single-stranded complementary DNA sequence, and detected using square wave 
voltammetry. Additionally, the ability to control the amount of DNA chemisorbed 
to the electrode surface was investigated by varying the incubation time in the 
probe solution. The measured current increased as the incubation time increased 
from 15 minutes to one hour, after which it plateaued. The use of an 
electrochemical biosensor is a promising alternative to qPCR for the 
quantification of DNA, with one hour being the optimal incubation time in the 
probe solution. 
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1.0 Introduction 
Characterizing peak height variation that occurs because of the forensic 
DNA laboratory process is necessary to properly interpret DNA results obtained 
from an item of evidence. This is particularly true when analyzing low-template or 
mixture samples. Therefore, the variability of the peak heights must be studied 
and characterized via validation experiments. As many parameters as is feasible 
should be evaluated, with a focus on those that have the greatest effect on the 
results. Additionally, pursuing alternate analysis methods, specifically for 
quantification, could help reduce the overall variation observed and lead to 
improved quantification methods.  
1.1 Typical Forensic STR Laboratory Methods 
Forensic DNA analysis is a multistep process, involving the extraction of 
DNA from the cells of a sample, the quantification and amplification of that DNA, 
and finally the separation and detection of the products that are formed. 
Typically, during the extraction step, the cells are digested with a proteinase to 
release the DNA into solution. After isolating the DNA, the sample is quantified, 
most often with the real-time quantitative polymerase chain reaction (qPCR), to 
determine how much DNA is present in the extract.1 Typically, absolute 
quantification in forensic laboratories utilizes a probe, labeled with a quencher 
and reporter dye, which hybridizes between the two primer binding sites on the 
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target DNA strand. As long as the probe is intact, the quencher prevents the 
fluorescent signal from the reporter dye from being detected. During the 
polymerization step of PCR, the DNA polymerase, which exhibits 5’-exonuclease 
activity, digests the probe. This releases the reporter and quencher dyes and the 
fluorescence from the reporter dye is detected. Therefore, in probe-based qPCR 
techniques, as the number of cycles of PCR increases and the amount of DNA 
product increases, the fluorescence increases.2 The cycle number at which the 
fluorescence reaches a user-set threshold, referred to as the cycle threshold (Ct), 
is recorded. By running samples of known concentrations and creating a 
standard curve by plotting the Ct value versus log(Concentration), the 
concentration of an unknown sample can be calculated.  
After quantification, short tandem repeat (STR) analysis is performed 
using multiplex PCR and a target mass of DNA. An STR is a non-coding section 
of DNA composed of a short sequence of nucleotides that is repeated multiple 
times.2 The number of times the sequence is repeated is variable within a 
population. Therefore, by amplifying multiple STR locations using multiplex PCR 
and determining which alleles are present, individuals can be differentiated from 
one another.3  
 Prior to PCR cycling, a solution of primers, deoxynucleotide triphosphates 
(dNTPs), and DNA polymerase is added to the DNA sample. The primers are 
short sequences of DNA that are complementary to flanking regions surrounding 
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STR areas of interest and will hybridize with their targets.  After hybridization the 
DNA polymerase synthesizes a new DNA strand. There are two primers for each 
STR, one for the forward strand and one for the reverse strand, one of which is 
labeled with a fluorescent dye that aids in subsequent detection. Within one PCR 
cycle, the DNA polymerase synthesizes the new DNA strand based on the 
sequence of the target strand. The newly synthesized double-stranded copies of 
DNA, called amplicons, use the dNTPs as the building blocks and Taq 
polymerase as the catalyst. The sample then undergoes thermal cycling, which 
continues to amplify the DNA. The thermal cycling parameters are as follows: the 
sample is heated to approximately 95°C to denature the double stranded DNA, 
after which the temperature is lowered to 50-65°C to allow the primers to anneal 
to their complementary sequences. The temperature is increased again to 70-
85°C for the elongation step, during which the DNA polymerase is able to 
synthesize the strand complementary to the genomic DNA, starting wherever a 
primer has annealed. Again the temperature is raised to 95°C to denature the 
newly formed strands from the genomic DNA, and the annealing and elongation 
process begins again.4 This process is repeated many times, resulting in an 
exponential increase in the amount of DNA present. An illustration of the first 
three cycles of PCR is presented in Figure 1. 
The amplified product must then be separated and detected in order to 
identify which STRs are present. This is accomplished using capillary 
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electrophoresis (CE), which separates the alleles based on size.  The sample is 
introduced into the capillary via electrokinetic injection, in which a positive voltage 
is applied to the sample and the negatively charged DNA is drawn into the 
capillary.5 Once in the capillary, the DNA migrates through the polymer, with the 
smaller strands having the fewest interactions with the polymer and, therefore, 
moving through the capillary the fastest. The DNA is then detected through 
fluorescence. A laser is directed through a window near the end of the capillary, 
and this laser excites the fluorophores attached to the primers. A charge-coupled 
device (CCD) detects the fluorescence, which is converted to an electrical signal 
and reported as a peak.2 The use of multiple fluorophores allows for the 
simultaneous detection of similarly sized DNA strands. The final result of this 
analysis is a DNA profile, reporting the alleles observed at each locus examined. 
This profile can be used for comparison purposes between samples of known 
and unknown origin.  
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Figure 1. Schematic of PCR chemistry for three cycles. The template DNA is denatured at 95°C 
(A). The temperature is lowered to 50-65°C and the primers, one of which is labeled with a 
fluorescent dye, anneal to the DNA (B). The temperature is increased to 70-85°C and the DNA 
polymerase synthesizes the complementary DNA strand of the target sequence (C). The final 
product after one cycle is one amplicon hybridized to the each of the original DNA strands (D). 
The process is repeated for the second cycle (E-G). The process occurs on both strands of DNA 
but is depicted for only one strand. The final product after two cycles is shown (H). In the third 
cycle, the strands are denatured again (I), and the PCR is repeated. The final product after this 
cycle is two amplicons of the target DNA sequence (J). 
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1.1.1 Variation in Current DNA Analysis 
Each step of the laboratory process is a source of error resulting in 
variation of the results obtained.  This is usually observed in the form of variation 
in the peak heights. Inaccuracies associated with qPCR have been previously 
studied. For example, a study conducted by the National Institute of Standards 
and Technology (NIST) examined the variation in DNA quantification between 
laboratories and within a laboratory. Forty-five laboratories were given five 
samples: one 5.0 ng/µL sample; one 2.5 ng/µL sample; two 1.0 ng/µL samples, 
which were prepared as duplicate samples; and one 0.5 ng/µL sample. Most 
participants obtained quantification results similar to the median value for the four 
concentrations. However, three had values five-fold higher than the median, and 
four had values four to forty-fold lower than the median value at 2 or more 
concentrations. The intra-laboratory variation was assessed using the two 1.0 
ng/µL samples. The intra-laboratory variation was determined to be the same as 
that observed between laboratories. Therefore, it was concluded that the 
variation was intrinsic to the quantification process and not caused by differences 
in laboratory practices.6 Similarly, Grgicak et al. observed that there is variation 
between concentrations obtained from the same samples quantified multiple 
times. It was determined that the variability in the dilutions used to make the 
calibration curves had a large effect on final results. Therefore, it was suggested 
that care must be taken when creating the calibration curve used to approximate 
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the DNA quantity in an unknown sample.7 If a large amount of variability in the 
quantification exists, an increased variability in the calculated concentrations of 
unknown samples is the result. Since PCR targets are based on quantification 
results, they can have a large impact on expected STR peak heights.  
There is also stochastic, or random, variation introduced during the 
amplification process. The efficiency of the reaction at each step—denaturation, 
annealing of primers, and elongation—will affect the results. If the efficiency were 
100% at each step, then there would be a doubling in the amount of DNA for 
each cycle of the PCR as per Equation 1.  𝐶! = 𝐶!(1+ 𝐸)!    (Equation 1) 
In this equation, Cn is the amount of DNA after n cycles of PCR, C0 is the initial 
amount of DNA, E is the efficiency of the reaction, and n is the number of cycles. 
Numerous studies have examined the effect of E on the PCR. For 
example, Booth et al. developed a mathematical model to calculate the overall 
efficiency of the PCR. Their model incorporated the individual efficiencies of 
denaturation, annealing, polymerase binding, and elongation. The resulting 
model was used to calculate the efficiencies over forty cycles of PCR at varying 
extension times and initial amounts of DNA. They were able to show that the 
individual efficiencies, as well as the overall PCR efficiency, varied as the 
number of cycles increased.8 Gill et al. assessed the whole laboratory process 
and modeled PCR using a binomial distribution, where the amplification 
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efficiency was not held constant at one, and showed that this is a good predictor 
of the observed peak height ratio discrepancies between heterozygous loci 
typically seen in forensic STRs.9 Gevertz et al. also developed a mathematical 
model for PCR efficiency based on experimental real-time PCR data. Their 
model incorporated equilibrium and kinetic equations and showed that the 
efficiency varies between each cycle and decreases as cycle number 
increases.10  
Further, preferential amplification is known to occur, where one allele 
amplifies with a higher efficiency than the other in a heterozygous pair.11,12 This 
results in peak height imbalance between the two alleles at the locus. Bright et al. 
have shown that the imbalance increases as the template amount decreases, 
and that as the difference in the number of repeats between alleles increases, 
the peak height imbalance increases.13 Further, Debernardi et al. showed that 
this peak height imbalance is not locus dependent.14 
Stutter is a PCR artifact that can also affect the observed peak height of 
the parent allele. It is observed as a peak typically one repeat shorter than the 
parent allele and is proposed to occur because of strand slippage during 
amplification. The decrease in peak height of the parent allele is due to the DNA 
being amplified as two different sequences. These stochastic effects have been 
observed to a higher degree in low-template samples, as evidenced by allelic 
drop-in, allelic or locus dropout, and an increase in stutter variation.2,12,15,16 
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In addition to the error associated with the scientific processes used in 
forensic DNA analysis, error can be introduced through sample preparation. The 
use of a dilution series to prepare standard samples has been shown to result in 
less accurate concentrations as the number of dilution steps increases.17 This is 
due to the propagation of error of volumes transferred during the pipetting 
process. Stochastic sampling effects such as the sample being unevenly 
distributed in solution or adsorbed to the tube can also result in variation.18,19 
Additionally, the number of copies of a particular allele present in the aliquot will 
be different than the number of copies of the sister allele.20 In extreme cases, 
such as low-template DNA detection, this may result in drop-out frequencies, 
which can be predicted by the Poisson distribution.21 These sources of variation 
cause peak height imbalance between two alleles within a locus or complete 
allele dropout. Therefore studies that aim to characterize the extent to which 
each source of error impacts the final result are of interest. 
1.1.2 Validation 
Because of the variation known to occur during DNA analysis, a method 
must be proven reliable and robust if it is to be utilized for forensic purposes. To 
do this, internal validations are performed to assess which factors impact 
analysis. During validation, analytical figures of merit which include, but are not 
limited to, sensitivity, repeatability, reproducibility, and limits of detection are 
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determined. The Scientific Working Group on DNA Analysis Methods 
(SWGDAM) defines the purpose of method validation as allowing scientists to 
“determine its efficacy and reliability for forensic casework and/or database 
analysis.”22 SWGDAM’s “Validation Guidelines for DNA Analysis Methods” and 
the Federal Bureau of Investigation’s (FBI) “Quality Assurance Standards for 
Forensic DNA Testing Laboratories” provide general guidance as to what should 
be included or considered during method validation.22,23 For example, SWGDAM 
recommends that at least 50 samples should be analyzed and that known and 
non-probative evidence samples should be examined. They also state the 
studies should be conducted to assess the following: sensitivity, stochastic 
effects, mixtures, precision, accuracy, and contamination. Other organizations, 
such as the American Society of Crime Laboratory Directors/ Laboratory 
Accreditation Board (ASCLD/LAB) and Eurachem, provide additional 
recommendations for validation and characterizing the uncertainty in 
measurement.24,25 
 However, the recommendations provided do not give minimum criteria or 
specific protocols that should be used during validation. To assess the current 
state of forensic DNA typing validation and the extent to which the process could 
be standardized, Butler et al. conducted a survey of 52 forensic analysts, 
interviewed several scientists in the field, and conducted a literature review of 
relevant peer-reviewed articles.26 It was determined that the number of samples 
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analyzed, and the extent to which the samples were evaluated, varied from 
laboratory to laboratory and was dependent on the specific needs of the 
laboratory. Additionally, many validation studies using different STR kits and 
instruments have been published.3,27–30 These studies mainly characterized the 
parameters recommended by SWGDAM, including sensitivity, stochastic effects, 
and reproducibility.   
 Although these validations examined the intrinsic variation that results 
from the limitations of the PCR chemistry and the instrument, none specifically 
examine the potential effect of day-to-day changes in the laboratory, such as 
changing a capillary or using a different kit lot. As Eurachem recommends that 
validation studies include as many factors that may contribute to the variation as 
is practical, validations may need to be expanded to include other sources of 
variation.25  
1.2 Electrochemical Biosensors 
Because of the error associated with qPCR, recent research has focused 
on developing methods for the direct detection of DNA, including the use of 
electrochemical biosensors.31–35 A biosensor is typically composed of a biological 
layer, often DNA or an enzyme, and a detector, which can be an electrode for 
electrochemical detection or an optical detector.36 The interaction of the 
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biological layer with the analyte of interest results in a measurable signal that is 
related to a property of the sample, such as the concentration of the target. 
In a DNA-based biosensor, a short ssDNA probe is usually used as the 
biological layer, and can be formed on a variety of detectors, including glassy 
carbon, gold, or platinum electrodes. The probe can be immobilized via several 
different mechanisms, including electrostatic adsorption or chemisorption of the 
DNA to the electrode surface.36 Electrostatic adsorption is achieved by applying a 
positive potential to the electrode, to which the negatively charged DNA 
backbone is attracted. During the chemisorption process, the modified DNA 
probe is chemically bound to the surface of an electrode, creating a single layer 
of DNA probes referred to as a self-assembled monolayer (SAM). Once the SAM 
has formed, the biosensor can be immersed in a solution of the denatured target 
DNA and the two components are allowed to hybridize. Analysis of the 
hybridization product can be performed using various indicator molecules 
detected via electrochemical measurements.35,37 
1.2.1   Gold-Based Electrochemical Biosensor 
Gold has been investigated as a detector for biosensors because it is 
reasonably inert, has a large anodic potential range, and has favorable electron 
transfer kinetics.31,38 These biosensors are currently being developed for several 
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purposes, including the detection of one-base mismatches in an oligonucleotide, 
the quantification of DNA, and molecular diagnostics.39–41  
For all applications, the gold electrode is typically modified with a probe 
such as an oligomer, enzyme, or alkyl chain to create the biological layer. This 
layer is most often formed via chemisorption. The probe, modified at one end 
with a thiol or disulfide, is able to covalently bond to the electrode surface 
through the formation of a gold-sulfur bond, creating the SAM. Several studies 
have sought to create and characterize the SAM on gold surfaces. Probes such 
as alkoxycyanobiphenyl thiols, cytochrome c oxidase, and oligonucleotides have 
been reported as successfully being used to create SAMs.42–44 Herne and Tarlov 
have shown that thiol-derivatized, ssDNA can interact with a gold film both 
through the covalent bonding of the sulfur atom of the thiol with gold and through 
non-specific interactions of the nucleic acids with the gold surface. However, by 
creating a mixed monolayer of the DNA probe and mercaptohexanol (MCH), an 
alkanethiol with a terminal hydroxyl group, the DNA was primarily adsorbed via 
the creation of sulfur-gold covalent bonds in a single layer, and little to no non-
specific adsorption occurred.45  
Levicky et al. expanded this research to visualize the effect of MCH on the 
formation of the SAM. Using neutron reflectivity to measure the distance of the 
DNA from the gold surface, the concentration profiles of the ssDNA on the 
electrode were determined before and after exposure to MCH. It was observed 
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that prior to the addition of MCH, the profile of the DNA was very compact, which 
suggested that the DNA had multiple points of contact with the electrode surface. 
After the electrode was exposed to MCH, the thickness of the profile increased, 
suggesting the ssDNA was being lifted off the surface of the electrode due to the 
MCH forming a layer with exposed hydroxyl groups, to which the ssDNA is not 
strongly attracted.46 Therefore, only the ssDNA that is covalently bound to the 
electrode would remain on the electrode surface in an upright position. The ability 
to control the formation of the SAM is essential to the development of a 
biosensor as a reliable and reproducible method of quantification for forensic 
DNA analysis. Additionally, this process promotes the formation of a single layer 
of DNA, and the orientation of the DNA allows for the hybridization of a target, 
which is subsequently detected via electrochemical techniques.  
1.2.2   Generating a Signal 
Several methods have been investigated to produce a measureable signal 
using an electrochemical biosensor. Direct methods do not require the addition of 
an indicator. For example, the change in capacitance after hybridization of the 
target to the SAM or the current produced from the oxidation of guanine residues 
present in the target can be used to determine the concentration of a sample.42,47  
Another possible method of detection is the use of an indicator molecule, 
which could be an intercalator or an electrostatic indicator. Intercalating 
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compounds, such as methylene blue and ethidium bromide, interact with double-
stranded DNA and insert themselves between the bases.36 Because intercalators 
do not interact with ssDNA, detection of a signal indicates that hybridization 
occurred. Electrostatic indicators interact with the negatively charged phosphate 
backbone of DNA. Because of the difference in charge densities between single-
stranded and double-stranded DNA, the electrostatic indicator will interact 
differently with the two types of DNA and therefore result in different signals.  
The DNA probe can also be labeled directly with an indicator molecule. 
Prior to hybridization, the indicator is able to interact with the surface of the 
electrode due the flexibility of the ssDNA, creating a signal. After hybridization of 
the target strand, the rigidity of the probe-target complex is increased, which 
causes in a decrease in the observed signal.37  
1.2.3 Electrochemical Techniques 
Several electrochemical techniques, such as coulometry and voltammetry, 
are available for the detection of the SAM and hybridized product using the 
signal-producing methods described previously.  Voltammetry examines the 
relationship between current and potential, or voltage, within an electrochemical 
cell.48 Two commonly used voltammetric techniques—square wave and linear 
sweep— are summarized below.  
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1.2.3.1   Square Wave Voltammetry 
Square wave voltammetry (SWV) is a form of pulse voltammetry, which 
measures the current produced after applying a potential pulse as a function of 
time.48 This method has been proven to be a very fast and sensitive analytical 
technique, detecting an analyte down to a concentration of 10-8 M.49  
The square wave voltammetry waveform is a combination of a 
symmetrical square wave pulse and a staircase waveform.50 Using the 
symmetrical square wave pulse, a potential is applied for a fixed period of time, 
with the application being almost instantaneous. This is identified as the positive 
pulse. The amplitude is the change in voltage between the pulse voltage and the 
initial voltage. After application, the potential returns immediately to the initial 
potential and is held there for a pulse width. This step is the negative pulse. One 
cycle consists of a positive and negative pulse.51 The waveform is depicted in 
Figure 2. 
17 
 
 
Figure 2. An example of a symmetrical square wave pulse waveform, where the amplitude is 1 V 
and the pulse width is 2 seconds. One cycle, consisting of a positive and negative pulse, takes 4 
seconds.  
  
 In a staircase waveform, the pulse width is kept constant, but the potential 
is increased with each step, or cycle.48 This step, ΔEs, is the same for each 
increase in potential. The waveform is depicted in Figure 3. 
 
 Pulse 
Cycle 1 
Amplitude 
POSITIVE 
PULSE 
NEGATIVE 
PULSE 
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Figure 3. An example of a staircase waveform, with ΔEs = 1 V and a pulse width of 2 seconds. 
 
Combining the symmetrical square wave pulse and staircase waveforms 
results in the square wave voltammetry waveform, which is presented in Figure 
4. The parameters defined for the individual waveforms are utilized, including 
pulse width, ΔEs, and the positive and negative pulses. The change in potential, 
ΔEp, is analogous to the amplitude of the symmetrical square wave pulse. The 
step of the staircase occurs at the end of the negative pulse of the symmetrical 
square wave pulse. The net current (inet) of the waveform is calculated as: 𝑖!"#   =    𝑖!"#$%$&'   –   𝑖!"#$%&'"   (Equation 2), 
where ipositive is the current from the positive pulse and inegative is the current of the 
negative pulse.49 The net current is reported versus the potential and appears as 
a peak. 
Pulse 
ΔE
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Figure 4. An example of a square wave voltammetry waveform, with ΔEp = 1 V, ΔEs = 0.5 V, and 
a pulse width of 1 second.  
 
To analyze the observed peak, a linear baseline is set and the height from 
the apex of the peak to the baseline is measured (Figure 5). The peak height can 
then be correlated to the concentration of the sample.48 
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Figure 5. An example of a square wave voltammogram, with ΔEp = 25 mV and ΔEs = 1mV, with 
the baseline indicated by the dashed grey line and the resulting peak height being 250 nA.  
 
1.2.3.2   Linear Sweep Voltammetry 
 
Linear sweep voltammetry (LSV), a direct current technique, scans 
between two potentials at a constant rate in one direction and the resulting 
current is measured. The cathodic sweep is the scan from the more positive to 
the more negative potential. In this direction, the electrode is increasingly able to 
reduce the target molecule. During the anodic sweep, from the more negative to 
more positive potential, the electrode is able to oxidize the target.52 An example 
of an LSV waveform for the anodic sweep is presented in Figure 6.53 This 
technique has been previously used as a detection method for biosensors and to 
desorb DNA from an electrode surface among other purposes.54,55 An example of 
a linear sweep voltammogram is presented in Figure 7.  
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Figure 6. An example of the linear sweep voltammetry waveform for three cycles, scanning 
between the potentials 0 V and 1 V at a rate of 0.25 V/s. 
 
Figure 7. An example of a linear sweep voltammogram, scanning between the potentials -0.25 V 
and -1.3 V at a rate of 0.1 V/s. 
 
Cycle 1 
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1.3  Purpose 
 Because there is the potential that previously unconsidered factors may 
impact the results obtained from validations of PCR-based forensic DNA analysis 
methods, it was of interest to examine day-to-day alterations that contribute to 
variation. Therefore, this research sought to examine the impact different 
capillary lots, injections, amplifications, and kit lots may have on the profiles 
obtained from forensic DNA analysis.  Specifically, the observed peak heights, 
peak height ratios (PHR), stutter, and drop-out rates were evaluated based on 
data obtained from electropherograms of one sample injected on multiple 
capillary lots, one sample injected multiple times on the same capillary, one 
sample amplified multiple times with one kit lot, and one sample amplified with 
multiple kit lots.  
 In addition to examining the effects of day-to-day laboratory alterations, 
the impact of preparing samples using a dilution series was investigated using an 
in silico model of the post-quantification sample preparation, PCR amplification, 
and CE separation and detection. Simulated samples that were created using a 
dilution series were compared to simulated samples that were amplified 
immediately following quantification (i.e. no dilution required), and the differences 
in the spread of the peak heights were examined.  
 Lastly, given the error associated with both qPCR and STR analysis, an 
alternative quantitation method was investigated to eliminate one of the two 
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amplifications in the hope of decreasing the variation observed. The development 
of a biosensor, with a 5’-end modified thiol and 3’-end modified methylene blue 
DNA probe on a gold disk electrode, was investigated as a potential 
quantification method for forensic DNA applications. The electrochemical 
analysis was conducted using square wave voltammetry, and the peak heights 
observed for the SAM and the post-hybridization layer were used as an identifier 
that the biosensor was performing as expected. After assessing the efficacy of 
creating the biosensor, the ability to control the amount of DNA chemisorbed to 
the electrode surface was examined. This was achieved by varying the time the 
electrode was incubated in the DNA probe solution and assessing any change in 
the observed peak heights.  
Understanding the variation that occurs in forensic DNA analysis, 
specifically variation that is the result of day-to-day laboratory changes and 
sample preparation techniques, could provide analysts with valuable information 
that would allow them to develop more robust and informative validation design.  
Additionally, alternative direct quantification methods, such as the biosensor, 
could lead to decreased error in the quantification of forensic samples, and 
therefore, more reliable results in the downstream processes of forensic DNA 
analysis. 
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2.0 Characterizing variability in DNA measurement due to laboratory 
alterations 
2.1   Methods 
2.1.1   Sample Preparation 
The samples analyzed in this study were previously prepared. Generally, 
three samples, A, B, and C, of known genotypes were used at six target 
amounts: 0.25, 0.125, 0.063, 0.031, 0.016, and 0.008 ng. All amplifications were 
performed using AmpFLSTR® Identifiler® Plus kits, which provide information on 
the following STR loci: D8S1179, D21S11, D7S820, CSF1PO, D3S1358, TH01, 
D13S317, D16S539, D2S1338, D19S433, vWA, TPOX, D18S51, D5S818, and 
FGA.56 Amelogenin, the sex-determining locus, is also characterized using this 
kit, but was not considered in this study. To characterize the uncertainty in peak 
heights associated with injections, a single sample preparation originating from a 
single amplification was subjected to four injections on one capillary.  To test the 
effect of using different capillaries, a single sample preparation was run on the 
ABI 3130 four times, using a different capillary lot for each injection. To test the 
deviation associated with the amplification and sample preparation process, the 
sample was amplified two to four times with one kit lot and injected once.  The 
impact of using different kit lots was examined by amplifying the extract with 
three additional kit lots. This resulted in a total of approximately 72 profiles for 
each parameter (i.e. injection, capillary, amplification, kit) tested.  
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2.1.2   Data Filtering 
The electropherograms were analyzed using GeneMapper IDX v 1.1.1 
(Applied Biosystems) with an RFU threshold of 1. The data was exported and 
using the known genotypes, all non-allele peaks were removed. In addition to the 
allele peak information, stutter in the n-4 position was retained. Both the allele 
and stutter peaks that were above specified RFU thresholds were considered for 
further analysis. The thresholds were applied on a per-color basis, using the 
values determine by Rakay et al. using Method 2 described therein.57 For blue, 
the threshold was 11 RFU; for green it was 13 RFU; for yellow it was 20 RFU; 
and for red it was 18 RFU. Any peak at or below these thresholds was 
considered indistinguishable from noise and therefore not interpreted. If an allele 
was homozygous, it was assumed that each allele contributed equally to the 
observed peak height, and the peak height was divided by two. The data were 
sorted by type according the parameter being studied (capillary, injection, 
amplification, or kit lot), target mass, sample number, and locus. The data 
collected from samples analyzed on different capillary lots were identified as 
Validation 1, the data collected from samples injected multiple times on one 
capillary were identified as Validation 2, the data collected from samples 
amplified multiple times with one kit lot were identified as Validation 3, and the 
data collected from samples amplified with different kit lots were identified as 
Validation 4.  
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2.1.3   Variation in Peak Heights and Peak Height Ratio 
The normalized peak heights (RFU/ng DNA) were calculated by dividing 
the observed peak height by the target amount.  The peak height ratio (PHR) 
was calculated by dividing the smaller peak height by the larger peak height in an 
allele pair for heterozygous loci.  For both sets of data, the normalized peak 
heights and the PHRs for all loci were plotted against the target amount. The 15 
STR loci were also examined individually at 0.25 ng, plotting the peak heights 
and PHRs versus locus.  
2.1.4   Variation in Peak Height and Peak Height Ratio Equivalency 
The peak height results were further summarized by examining the ‘peak 
height equivalency’ (PHE) for every allele at the different target amounts.  To 
calculate the PHE, the sorted data was further separated by locus and allele.  
Once organized, each of the observed peak heights for a given allele at a target 
was divided by the largest observed peak height for that allele (PHmax).  This 
resulted in a ratio between 0 and 1.  Therefore, for parameters with high levels of 
reproducibility, all four peak height ratios would be close to 1. For example, for 
Sample C amplified using 0.031 ng of DNA, the four peak heights of the smaller 
allele when kit lots 1, 2, 3, and 4 were used were 104, 18, 34, and 140 RFU, 
respectively (Figure 8). Therefore the PHEs were calculated to be 104/140 = 
0.74, 18/140 = 0.13, and 34/140 = 0.24 for this allele at this target. Similarly the 
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PHEs for the second allele were 0.57, 0.23, and 0.14. The results were then 
combined and plotted as a cumulative distribution.  A separate plot was created 
for each target using the auto-binning function provided in IGOR Pro v 6.2 
(WaveMetrics, Inc.) and the data was fitted to a Gaussian cumulative density 
function.  Although Gaussian was not the best fit at lower targets for the injection 
and capillary data, it was chosen because it was a good fit for all data sets at the 
higher targets. The fit was not used to make any conclusion about the distribution 
of the values, but rather to allow for a relative comparison between the 
experimental designs using the means and standard deviations of the curves. 
 
Figure 8. Raw data from the amplification of Sample C at 0.031 ng of DNA with (A) kit lot 1, (B) 
kit lot 2, (C) kit lot 3, and (D) kit lot 4. The height of each peak is listed above the peak. 
 
 A similar analysis was performed for the PHR data. Once the data was 
organized by target, sample, and locus, the ‘PHR equivalency’ (PHRE) was 
calculated. Each PHR within a locus and sample was divided by the largest PHR 
in the set (PHRmax). Like the PHE, this resulted in a value between 0 and 1. For 
example, for Sample C amplified at 0.031 ng of DNA, the four peak height ratios 
for kit lots 1, 2, 3, and 4 were 0.90, 0.11, 0.89, and 0.16, respectively (Figure 8). 
A B C D 
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Therefore the PHREs were calculated to be 0.12, 0.99, and 0.18 at this target. 
The results for all loci within a parameter were combined and plotted as a 
cumulative distribution. A separate plot was created for each target and fitted 
with a cumulative Gaussian curve. 
2.1.5   Variation in Stutter  
 The stutter percentage was calculated by dividing the peak height of the 
stutter peak by the peak height of the allele peak and then multiplying it by 100. 
Column graphs were created in IGOR Pro v 6.2 (WaveMetrics, Inc.) for the four 
parameters, depicting the average stutter proportion ± one standard deviation at 
each locus. The graphs were only created for the 0.25 ng samples.  
2.1.6   Variation in Allele Detection Rates  
 True positive detection rates were measured by the number of observed 
alleles divided by the number of expected alleles in a profile. This was performed 
for each run within a parameter for all samples at the six targets. A plot of the 
four parameters’ ratios against target was generated. Additionally, the total true 
positive rate for a parameter was calculated as the total number of observed 
alleles divided by the total number of expected alleles for the four runs. This was 
plotted on the same graph as the data from the individual runs. An exponential fit 
was applied to the total true positive values of each parameter. Using the 
parameters and equation of the fitted curve, the probability of “non-drop-out” 
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(Pr(𝐷𝑂)) was calculated at 0.031, 0.016, and 0.008 ng. This was used to 
calculate the probability of drop-out (Pr(DO)) at each target using the equation: Pr 𝐷𝑂 = 1− Pr  (𝐷𝑂)                       (Equation 3). 
 The maximum peak height at which the sister allele dropped out was also 
identified for each parameter at 0.008, 0.016, and 0.031 ng.   
2.2 Results 
2.2.1   Injections on Multiple Capillary Lots versus Multiple Injections on 
One Capillary Lot 
 
 Routine changes to laboratory equipment, such as the replacement of a 
spent capillary, may have an effect on DNA signal.  Therefore, to determine 
whether changes in capillary lot significantly impacted peak heights, their ratios, 
the frequency of drop-out, and stutter, the data obtained from the same sample 
preparation injected four times on one capillary (Validation 2) was compared to 
the data obtained from one sample preparation injected one time using four 
different capillary lots (Validation 1).  
A comparison of the normalized peak heights obtained from the data sets 
Validations 1 and 2 for all loci at the six targets examined is presented in Figure 
9. This shows that, at 0.0156, 0.0313, 0.0625, and 0.25 ng, the peak heights 
obtained when the capillary was changed had a slightly greater spread than 
when a sample was injected multiple times on the one capillary. Further, it is 
observed that the spread in peak heights for both Validations 1 and 2 is impacted 
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by the target mass, signifying that the uncertainty in peak height is impacted by 
the presence of low-template quantities of DNA. The 15 STR loci were examined 
individually at 0.25 ng as well, and it was observed that at 11 loci the use of 
multiple capillaries resulted in a slightly greater spread compared to the use of 
multiple injections (Figure 10). The trend observed at the individual loci supports 
the trend seen when all loci were combined at that target.  
 
Figure 9. Normalized peak heights for Validation 1 (+) and Validation 2 () by target. 
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Figure 10. Normalized peak heights for Validation 1 (+) and Validation 2 () by locus at 0.25 ng. 
 
When the data was summarized for all loci, the cumulative histograms for 
‘peak height equivalency’ (PHE), fit with a Gaussian curve, showed that at all 
targets there was a difference between the data obtained from Validations 1 and 
2 (Figure 11). For example, at 0.125 ng, the average PHE for Validation 1 was 
0.885±0.008, compared to an average of 0.948±0.003 for Validation 2. Also, the 
width of the PHEs for Validation 1 was 0.11±0.01, whereas the width of the PHEs 
for Validation 2 was 0.044±0.006 at this target. The means and widths of the two 
parameters are summarized for the six targets in Table 1.  
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Figure 11. Normalized, cumulative histograms of the peak height equivalency for Validations 1 
(+), 2 (), 3 (Δ), and 4 (✕) for (A) 0.25, (B) 0.125, (C) 0.063, (D) 0.031, (E) 0.016, and (F) 0.008 
ng. The histograms were fit with a cumulative Gaussian curve. 
 
 
 
 
A B 
C D 
E F 
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Table 1. Mean and standard deviation values for the cumulative Gaussian fit of the peak height 
equivalency histograms for Validations 1, 2, 3, and 4.  
 
 
The PHRs for Validations 1 and 2 were also examined, and a comparison 
of the two for all loci at the six targets is shown in Figure 12. Across all targets, 
changes in the capillary did not increase the spread of the PHRs. When each 
locus was examined individually at 0.25 ng, the same trend was observed 
(Figure 13).  
Target  
(ng) Validation Parameter Mean (1 SD) 
Standard Deviation 
(1 SD) 
0.25 
1 Capillary Lot 0.891(0.007) 0.10 (0.01) 
2 Injection 0.969(0.001) 0.027(0.001) 
3 Amplification 0.716(0.005) 0.22(0.01) 
4 Kit Lot 0.710(0.006) 0.23(0.01) 
0.125 
1 Capillary Lot 0.885(0.008) 0.11(0.01) 
2 Injection 0.948(0.003) 0.044(0.006) 
3 Amplification 0.65(0.01) 0.28(0.03) 
4 Kit Lot 0.635(0.008) 0.28(0.01) 
0.063 
1 Capillary Lot 0.819(0.009) 0.14(0.01) 
2 Injection 0.949(0.001) 0.040(0.003) 
3 Amplification 0.340(0.006) -0.34(0.01) 
4 Kit Lot 0.506(0.007) 0.35(0.01) 
0.031 
1 Capillary Lot 0.863(0.007) 0.13(0.01) 
2 Injection 0.940(0.004) 0.055(0.008) 
3 Amplification 0.41(0.01) 0.42(0.03) 
4 Kit Lot 0.423(0.009) 0.40(0.01) 
0.016 
1 Capillary Lot 0.862(0.007) 0.11(0.01) 
2 Injection 0.920(0.004) 0.07(0.01) 
3 Amplification 0.40(0.01) 0.40(0.03) 
4 Kit Lot 0.45(0.01) 0.40(0.03) 
0.008 
1 Capillary Lot 0.857(0.005) 0.12(0.01) 
2 Injection 0.878(0.009) 0.10(0.01) 
3 Amplification 0.42(0.01) 0.38(0.03) 
4 Kit Lot 0.46(0.02) 0.42(0.04) 
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Figure 12. Peak height ratios for Validation 1 (+) and Validation 2 () by target. 
 
 
Figure 13. Peak height ratios for Validation 1 (+) and Validation 2 () by locus at 0.25 ng. 
 
The ‘PHR equivalencies’ (PHRE) are presented in Figure 14. All targets 
except 0.016 ng exhibited little difference between the two parameters, with the 
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widths of the fitted curves being very similar (Table 2). For example, at 0.25 ng, 
the data from both Validation 1 and Validation 2 had a width of 0.017, with a 
standard deviation of 0.002 for Validation 1 and 0.001 for Validation 2. However, 
at 0.016 ng, Validation 2 had a slightly wider spread of 0.07 ± 0.01, while the 
width was 0.05 ± 0.01 for Validation 1.  
 
Figure 14. Normalized, cumulative histograms of the peak height ratio equivalency for Validations 
1 (+), 2 (), 3 (Δ), and 4 (✕) for (A) 0.25, (B) 0.125, (C) 0.063, (D) 0.031, (E) 0.016, and (F) 0.008 
ng. The histograms were fit with a cumulative Gaussian curve. 
A B 
C D 
E F 
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Table 2. Mean and standard deviation values for the cumulative Gaussian fit of the peak height 
ratio equivalency histograms for Validations 1, 2, 3, and 4.  
Target 
(ng) Validation Parameter Mean (1SD) 
Standard Deviation 
(1SD) 
0.25 
1 Capillary Lot 0.981 (0.001) 0.017 (0.003) 
2 Injection 0.980 (0.001) 0.017 (0.001) 
3 Amplification 0.77 (0.01) 0.20 (0.03) 
4 Kit Lot 0.75 (0.02) 0.23 (0.04) 
0.125 
1 Capillary Lot 0.973 (0.002) 0.024 (0.004) 
2 Injection 0.974 (0.001) 0.020 (0.003) 
3 Amplification 0.68 (0.01) 0.25 (0.03) 
4 Kit Lot 0.70 (0.01) 0.25 (0.03) 
0.063 
1 Capillary Lot 0.927 (0.003) 0.054 (0.007) 
2 Injection 0.939 (0.003) 0.047 (0.006) 
3 Amplification 0.60 (0.04) 0.33 (0.08) 
4 Kit Lot 0.58 (0.02) 0.33 (0.03) 
0.031 
1 Capillary Lot 0.906 (0.008) 0.08  (0.01) 
2 Injection 0.905 (0.009) 0.07 (0.01) 
3 Amplification 0.61 (0.04) 0.35 (0.08) 
4 Kit Lot 0.57 (0.02) 0.33 (0.04) 
0.016 
1 Capillary Lot 0.921 (0.005) 0.05 (0.01) 
2 Injection 0.907 (0.007) 0.07 (0.01) 
3 Amplification 0.57 (0.04) 0.37 (0.08) 
4 Kit Lot 0.47 (0.01) 0.33 (0.03) 
0.008 
1 Capillary Lot 0.88 (0.02) 0.11 (0.04) 
2 Injection 0.848 (0.007) 0.10 (0.01) 
3 Amplification 0.54 (0.03) 0.28 (0.06) 
4 Kit Lot 0.6 (0.1) 0.3 (0.3) 
 
In addition to peak heights and PHRs, stutter percentages were 
considered when evaluating the effect of changing a capillary. The average 
stutter percentage at each locus for the two parameters is presented in Figure 
15. Stutter thresholds were also calculated as the average plus three times the 
standard deviation and are listed above each average percent stutter in Figure 
15. Both analyses suggest that changing the capillary lot does not have an effect 
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on stutter. The averages and thresholds are very similar, and one experimental 
design does not consistently have the higher thresholds. At eight of the fifteen 
loci, the thresholds would be the same; at three loci Validation 2 would result in a 
higher threshold by at most 2%; and at three loci Validation 1 would result in a 
higher threshold by 1%. No comparison was performed at TPOX because only 
one instance of stutter was observed for the multiple injections.  
 
Figure 15. Average percent stutter ± 1 standard deviation for Validation 1 (light grey) and 
Validation 2 (dark grey) at 0.25 ng. The value listed above the average percent stutter is the 
stutter threshold, calculated as the average + 3 standard deviations. 
 
 Common practice in the laboratory is to use a stutter threshold to 
determine if a peak in the stutter location is stutter or an allele peak. These 
thresholds can be established on a profile or locus basis, and chosen as a value 
that includes a certain percentage of the stutter observed during validation or as 
the average stutter percentage observed plus three standard deviations.62 Using 
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the last methodology, the use of different capillaries would not result in different 
thresholds compared to the use of multiple injections during validation.  
 While the use of a threshold is practical for single source samples, 
problems arise when thresholds are applied to mixtures. A peak from a minor 
contributor may be in the stutter position of a major contributor’s allele peak and 
below the stutter threshold. Therefore, the peak would be improperly identified as 
stutter. Because of this, recent research has investigated the use of a 
probabilistic methods that evaluate the probability that a peak is stutter versus a 
true allele peak.63–66  
Lastly, the rate of detection was determined and compared for the two 
data sets. For all targets, the rate of observed alleles was consistent between the 
two sets of data (Figure 16). An exponential fit was applied to each data set, 
which was used to calculate the probability of drop-out (Pr(DO)) for the three 
lowest targets (Table 3). The maximum peak height at which a sister allele 
dropped out was also identified for the three lowest targets (Inset in Figure 16). 
Drop-out can be assessed and utilized in the laboratory in two ways: a 
stochastic threshold can be established or a probabilistic model can be used.  In 
a laboratory that uses a probabilistic method, the Pr(DO)—determined through 
validation—is often incorporated into the calculation of the likelihood ratio (LR), a 
match statistic that states how much more likely it is that one hypothesis (usually 
the prosecution’s) is than another (usually the defense’s).67 With the calculated 
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Pr(DO) for both experimental designs being the same at the three lowest targets, 
there is no difference in drop-out between the two experimental designs.  
In a laboratory that uses a stochastic threshold, an RFU value is chosen 
based on validation results below which a certain percentage, for example 99%, 
of the heterozygous peaks whose sister allele dropped out are included.62 
Contrasting the results of the probabilistic method, the maximum peak height 
observed for which the sister allele dropped out was slightly higher for Validation 
1 than for Validation 2 at the lowest three targets (Inset in Figure 16). Therefore, 
this data suggests that in laboratories that use stochastic thresholds determined 
through internal validations, use of multiple capillary lots during validation may be 
deemed appropriate.  
 
Figure 16. Rate of detection for Validation 1 ( ) and Validation 2 (), with the total for each 
parameter being represented by the black, solid shapes and the individual runs for each 
parameter being represented by the grey, open shapes. The inset identifies the maximum peak 
height of the observed allele when the sister allele dropped out for the three lowest targets.  
 
40 
 
Table 3. The parameters A and B obtained from fitting the rate of detection plots with an 
exponential curve and the probability of drop-out (Pr(DO)) at 0.031, 0.016, and 0.008 ng for 
Validations 1, 2, 3, and 4 calculated from the probability of “non-drop-out” using Equation 3.  
Validation Parameter A B Pr(DO)0.031 Pr(DO)0.016 Pr(DO)0.008 
1 Capillary Lot -0.8 40 0.2 0.4 0.6 
2 Injection -0.8 40 0.2 0.4 0.6 
3 Amplification -1.3 150 0.02 0.1 0.4 
4 Kit Lot -0.74 53 0.1 0.3 0.5 
 
2.2.2   Multiple Injections on One Capillary Lot versus Multiple 
Amplifications with One Kit Lot  
 
The difference in variability between injecting a sample multiple times on 
one capillary (Validation 2) and amplifying a sample multiple times with one kit lot 
(Validation 3) was also examined. A comparison of the normalized peak heights 
for Validations 2 and 3 is presented in Figure 17. Visual inspection revealed that, 
at all targets except 0.125 ng, Validation 3 had a wider spread in peak heights. At 
0.125 ng, the spreads were comparable. Additionally, for both designs, it is 
observed that as the target decreased, the spread increased. Like Validation 1, 
this signifies that the uncertainty in peak heights is affected by low-template 
samples. When the 15 STR loci were examined individually at 0.25 ng, overall 
the distribution of peak heights was similar, with no locus having significantly 
higher or lower peak heights than the other loci (Figure 18). Additionally, the loci 
demonstrated the same trend as when the loci were examined together at 0.25 
ng.  
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Figure 17. Normalized peak heights for Validation 2 () and Validation 3 (Δ) by target. 
 
 
Figure 18. Normalized peak heights for Validation 2 () and Validation 3 (Δ) by locus at 0.25 ng. 
 
Further, when the data were summarized for all loci at each target through 
the PHE, Validation 3 was again found to have a wider distribution when fit with a 
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cumulative Gaussian curve compared to Validation 2 (Figure 11). For example, 
at 0.016 ng, the average of the curve for Validation 3 was 0.40±0.01 and the 
width was 0.40±0.03, while the average and width of the curve for Validation 2 
were 0.920±0.004 and 0.07±0.01, respectively. This trend was seen for all 
targets (Table 1).  
When a comparison of the PHRs was conducted, Validations 2 and 3 had 
similar spreads at 0.063 ng, 0.125 ng, and 0.25 ng, while at the lowest three 
targets, the multiple amplifications resulted in a slightly greater spread (Figure 
19). At 0.25 ng, when the loci were examined individually, greater spreads were 
observed for Validation 3 at 8 loci (Figure 20). At two loci, vWA and TPOX, the 
spreads were comparable; however, at vWA, Validation 2 had an overall higher 
PHR, and at TPOX, Validation 3 resulted in an overall higher PHR. Additionally, 
at D5S818, Validation 2 resulted in a slightly wider spread. This suggests that 
there is a difference between the two experimental designs at 0.25 ng. These 
results differ from the observation made when the loci were combined at the 
same target amount. This suggests that, while overall the PHRs are similar 
between the two designs, the PHRs of the individual loci are affected differently 
by multiple amplifications and injections.  
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Figure 19. Peak height ratios for Validation 2 () and Validation 3 (Δ) by target. 
 
Figure 20. Peak height ratios for Validation 2 () and Validation 3 (Δ) by locus at 0.25 ng. 
 
The PHREs for Validations 2 and 3 were observed to be different for all 
targets, with Validation 2 having greater reproducibility in PHRs (Figure 14). For 
example at 0.063 ng, when the data were fit with a cumulative Gaussian curve, 
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Validation 2 had a mean of 0.939±0.003 and a width of 0.047±0.006. These 
values indicate that Validation 2 resulted in more reproducible PHRs than 
Validation 3, which had a mean of 0.60±0.04 and a width of 0.33±0.08. The 
results for all targets are presented in Table 2.  
 The comparison of the effect of injections and amplifications on stutter 
was performed using the average percent stutter for each locus as well as the 
stutter threshold, or the average plus three standard deviations. The averages 
are plotted in Figure 21, and the thresholds are listed above each average. There 
appeared to be differences between the two designs; however, one experimental 
design did not consistently result in the higher threshold or have the higher 
average. At seven loci, Validation 3 resulted in a threshold 1-2% higher than 
Validation 2, while at three loci Validation 2 resulted in a higher threshold by 1%. 
At four loci, the two experimental designs would result in the same threshold. As 
previously mentioned, a threshold could not be calculated for the injection data at 
TPOX, and therefore, no comparison was made at this locus. If a laboratory uses 
internally determined stutter thresholds based on a validation study, Validation 3 
would more often result in the higher threshold.  
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Figure 21. Average percent stutter ± 1 standard deviation for Validation 2 (light grey) and 
Validation 3 (dark grey) at 0.25 ng. The value listed above the average percent stutter is the 
stutter threshold, calculated as the average + 3 standard deviations. 
 
 The rate of detection was also considered when evaluating the effect of 
different injections and different amplifications. Figure 22 demonstrates that, at 
the highest three targets, the observed allele rate was the same for the two 
validation experiments. However, for the lowest three targets, 0.031, 0.016, and 
0.008 ng, there were visible differences in the rates of allele detection. The total 
amount of detection was lower for Validation 2. However, the reproducibility was 
greater between individual injections as compared to the individual 
amplifications, which is depicted by the grey circles and triangles in Figure 22. 
The fit of the total rates for each design using an exponential curve confirmed the 
difference in detected alleles between Validations 2 and 3, with the Pr(DO) being 
higher at the three lowest targets for Validation 2 compared to Validation 3 (Table 
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3). For example, at 0.008 ng, the Pr(DO) for Validation 2 was 0.6, while for 
Validation 3 it was 0.4.  
In a laboratory that uses a probabilistic model for drop-out, Validation 2 
would result in a higher Pr(DO), and therefore, all future LRs calculations would 
be affected. However, the difference in the rate of drop-out, and therefore LR, 
may be due to the amplification of the sample used for the multiple injections, as 
opposed to the injections themselves, as the amplifications have been shown to 
have highly variable results and the drop-out rate for different injections was very 
reproducible between runs.  
For a laboratory that uses a stochastic threshold, if the threshold was 
chosen to include 100% of the peak heights for which a sister allele dropped out, 
Validation 3 always resulted in the highest threshold. The maximum peak height 
observed where the sister allele dropped out was higher at the three lowest 
targets for Validation 3 compared to Validation 2 (Inset in Figure 22). This may 
be the direct result of the larger variation in peak heights expected between 
amplifications. 
Overall, the results obtained demonstrated that Validation 2 resulted in a 
lower stochastic threshold but a higher Pr(𝐷𝑂). This shows that one amplification 
injected multiple times is not sufficient for determining the Pr(𝐷𝑂) or stochastic 
threshold. If this method was used, the drop-out model or threshold may be 
based on an amplification outlier. 
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Figure 22. Rate of detection for Validation 2 () and Validation 3 (Δ), with the total for each 
parameter being represented by the black, solid shapes and the individual runs for each 
parameter being represented by the grey, open shapes. The inset identifies the maximum peak 
height of the observed allele when the sister allele dropped out for the three lowest targets.  
 
2.2.3   Multiple Amplifications with One Kit Lot versus Amplification with 
Multiple Kit Lots  
 
 Determining if there is a difference in variation between a sample 
amplified multiple times with one kit lot (Validation 3) and a sample amplified with 
multiple kit lots (Validation 4) was also of interest. Figure 23 presents the 
normalized peak heights of all loci combined for Validations 3 and 4. At 0.25 and 
0.125 ng, there was no difference in the spread of the peak heights. However, at 
the lowest four targets, Validation 3 had a larger spread. When the 15 STR loci 
were examined individually at 0.25 ng, most loci had similar spreads between the 
two designs (Figure 24). The spread was greater for Validation 3 at four loci and 
for Validation 4 at two loci. The results for the individual loci agreed with the 
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results with the loci combined. When the PHEs were considered, the two 
experimental designs had similar means and widths, with neither consistently 
having the larger values across the targets (Figure 11). For example at 0.031 ng, 
the widths for Validation 3 and Validation 4 were 0.42±0.03 and 0.40±0.01, 
respectively, while at 0.008 ng, the widths for Validation 3 and Validation 4 were 
0.38±0.03 and 0.42±0.04, respectively. The means at 0.031 ng were 0.41±0.01 
for Validation 3 and 0.423±0.009 for Validation 4, and at 0.008 ng they were 
0.42±0.01 for Validation 3 and 0.46±0.02 for Validation 4. The means and widths 
for the remaining targets are presented in Table 1. 
 
Figure 23. Normalized peak heights for Validation 3 (Δ) and Validation 4 (✕) by target.  
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Figure 24. Normalized peak heights for Validation 3 (Δ) and Validation 4 (✕) by locus at 0.25 ng. 
 
 For the PHRs, Validations 3 and 4 had similar results at all targets when 
the loci were combined (Figure 25). When the loci were considered separately at 
0.25 ng, the same trend was observed at 11 of the 15 loci (Figure 26). At the 
remaining four loci, Validation 4 demonstrated a slightly larger spread in PHRs. 
The similarity in distributions is supported by the PHREs (Figure 14). At 0.25 and 
0.008 ng, Validation 4 resulted in a greater spread, while at 0.031 and 0.016 ng 
Validation 3 resulted in a greater width. At the remaining two targets, 0.125 and 
0.063 ng, the two experimental designs had the same curve width. All means and 
widths are presented in Table 2. 
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Figure 25. Peak height ratios for Validation 3 (Δ) and Validation 4 (✕) by target. 
 
 
Figure 26. Peak height ratios for Validation 3 (Δ) and Validation 4 (✕) by locus at 0.25 ng. 
 
 For the stutter percentages, the two designs had similar average percent 
stutters for each locus (Figure 27). However, the standard deviations were 
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different at several of the loci, resulting in different thresholds, which are listed 
above the average percentages for each locus in Figure 27. The thresholds for 
Validation 4 were higher than those for Validation 3 at 8 loci, ranging from 1-2% 
higher. Validation 3 resulted in a threshold 1% higher than that of Validation 4 at 
one locus, and the thresholds were the same at the remaining six loci. If 
internally determined stutter thresholds were used, Validation 4 would result in 
higher thresholds at over half of the loci examined, and therefore, multiple kit lots 
should be examined.  
 
Figure 27. Average percent stutter ± 1 standard deviation for Validation 3 (light grey) and 
Validation 4 (dark grey) at 0.25 ng. The value listed above the average percent stutter is the 
stutter threshold, calculated as the average + 3 standard deviations. 
 
 The rate of detection was also evaluated (Figure 28). Down to 0.063 ng, 
the two experimental designs exhibited the same rate of detection. However, as 
the target decreased, fewer alleles were observed in the profiles from Validation 
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4 as compared to the profiles from Validation 3. The difference between 
Validation 3 and Validation 4 is supported by the different curves observed for 
the totals of each parameter. The calculated probabilities of dropout are 
presented in Table 3.  
The results obtained could be of importance for validation purposes in 
laboratories that use a probabilistic method, as the two experimental designs 
demonstrated different probabilities of drop-out at the three targets examined. 
This would translate to a difference in calculated LRs. However, only four runs 
were evaluated for each experimental design, and therefore, further investigation 
into this phenomenon could be of great value to an analyst when deciding if 
multiple kit lots should be validated. Contrastingly, in laboratories that utilize a 
stochastic threshold, evaluating multiple kit lots would not be necessary given 
this data. Validation 3 had the higher observed peak height where a sister allele 
dropped out as compared to Validation 4 at the three lowest targets, 0.008, 
0.016, and 0.031 ng (Inset in Figure 28). However, further studies would be 
needed to confirm this. 
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Figure 28. Rate of detection for Validation 3 (Δ) and Validation 4 (     ), with the total for each 
parameter being represented by the black, solid shapes and the individual runs for each 
parameter being represented by the grey, open shapes. The inset identifies the maximum peak 
height of the observed allele when the sister allele dropped out for the three lowest targets.  
 
3.0 Dynamic model of the effect of a dilution series on PCR-based DNA 
measurement 
3.1 Methods 
3.1.1 Purpose of the Dynamic Model 
 
 A dynamic model was designed using STELLA 9.1.4 (isee systems, 
Lebanon, NH) in order to determine the effect serially diluting samples has on the 
peak heights. Therefore samples serially diluted after quantification could be 
compared to samples that were not diluted. By creating an in silico model, 
hundreds of “samples” could be run and an assessment of the effect of error 
propagation on the peak heights could be evaluated.  
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3.1.2 Model Development and Structure 
 
The model depicts the DNA laboratory process—from the post-
quantification sample preparation through the separation of the samples on the 
capillary electrophoresis. The diagrammatic representation of the full model is 
presented in Figure 29. In the following sections, the model is broken down into 
the 1) dilution series, 2) PCR, and 3) capillary electrophoresis processes. Each 
parameter within that section of the model is defined. All calculated values are 
based on data from samples analyzed using the Identifiler® Plus STR 
amplification kit. 
 
Figure 29. Dynamic model of PCR-based DNA analysis. 
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3.1.2.1   The Dilution Series:  
This section of the model mimics the creation of a dilution series in the 
laboratory from a stock solution of 1000 ng/µL (Figure 30). The ‘pipettes’ used for 
the simulated dilutions were the 1-10 µL, 10-100 µL, and 100-1000 µL pipettes, 
as these are commonly found in forensic DNA laboratories. The standard 
deviations for the pipettes were 0.120, 0.8, and 8.0 µL, respectively, and were 
based on the maximum allowed deviation for working pipettes based on 
ISO8655.58 The lowest-volume pipette possible was used during the dilutions. 
For example, if 100 µL were pipetted, the 10-100 µL pipette was used as 
opposed to the 100-1000 µL pipette. The components of the dilution simulation 
are defined below. 
 
Figure 30. Dilution series used in the dynamic model of PCR-based DNA analysis. 
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For the samples that undergo dilution post-quantification (Sample Set 1), 
the DNA stock amount was set to 1000 ng/µL, with a standard deviation of 60 
ng/µL, and the distribution was assumed to be normal. This was based on a 6% 
relative standard deviation in qPCR quantification values, as determined from 
prior research conducted within the laboratory.59 The stock amount was diluted 
serially to final concentrations of 0.25, 0.125, 0.063, 0.031, 0.016, and 0.008 
ng/µL. For the 5 highest targets, two dilution steps were performed, while for the 
lowest target, three dilution steps were performed. The concentration after each 
step, denoted as Dilution 1, Dilution 2, and Dilution 3 in Figure 10, was calculated 
as: 𝐶! = 𝐶!!! !"#$%&(!,!.!"#)!"#$%&(!,!.!"#)!!"#$%&(!,!!)   (Equation 4), 
where Cn is the concentration after dilution step n, Cn-1 is the concentration of the 
solution prior to dilution step n, y is the volume taken from that solution, b is the 
volume of the buffer added to create the new concentration, and σb is the 
standard deviation of the volume transferred. The volume used during a dilution 
step was assumed to be normal, with σb representing the maximum allowed 
deviation for the pipette used. The volume y was 1 µL, and was assumed to be 
normally distributed with a standard deviation of 0.120.58 The values of b and σb 
of each dilution step for the six targets are listed in Table 4. 
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Table 4. Values of b and σb for each dilution step for the six targets of interest.  
Final Target 
Concentration 
(ng/µL) 
Dilution 1 Dilution 2 Dilution 3 
b (µL) σb58 (µL) b (µL) σb58 (µL) b (µL) σb58 (µL) 
0.25 99 0.80 39 0.80 0 0 
0.125 99 0.80 79 0.80 0 0 
0.063 99 0.80 159 8.0 0 0 
0.031 99 0.8 318.5 8.0 0 0 
0.016 99 0.80 640 8.0 0 0 
0.008 99 0.80 9 0.120 127 8.0 
 
For the samples that are not serially diluted (Sample Set 2), the same 
targets were used. The target amount of DNA was put directly into the PCR, 
without any dilution being performed. The standard deviation was calculated as 
6% of the target amount and the distribution was assumed to be normal. The 
targets and their associated standard deviations are listed in Table 5. 
Table 5. Target amount and standard deviation, calculated as 6% of the target amount, used for 
stock solution of quantified samples. 
Target Amount 
(ng/µL) 
Standard deviation 
(ng/µL) 
0.25 0.015 
0.125 0.0075 
0.063 0.00375 
0.031 0.00188 
0.016 0.000936 
0.008 0.000469 
 
58 
 
3.1.2.2   The Polymerase Chain Reaction (PCR):  
This section of the model represents the amplification of the DNA through 
29 cycles of PCR, after the DNA is diluted to the target concentration (Figure 31), 
and was designed to mimic the PCR using the Identifiler® Plus amplification kit.   
 
 
Figure 31. Model of the polymerase chain reaction. 
 
One microliter of the final DNA solution, from Dilution 3 for Sample Set 1 
or directly from the stock solution for Sample Set 2, was used in the amplification. 
The standard deviation of the volume transfer was 0.120 and assumed to be 
normal. Once the DNA entered the PCR, the reaction was run for 29 cycles.56 
The amount of DNA after each cycle was calculated as: 𝐶! = 𝐸 ∗ 𝐶!!!    (Equation 5), 
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where Cn is the amount of DNA after n cycles, Cn-1 is the amount of DNA after 
the previous cycle, and E is the efficiency of the reaction. In an ideal situation, 
the amount of DNA would double every cycle, and therefore, E would be equal to 
1. However, the depletion of reagents, the accumulation of PCR product, and the 
decreased efficiency of the DNA polymerase can cause the efficiency to 
decrease as the cycle number increases.8  
Two factors were considered when calculating the efficiency of the 
reaction: the natural variation and the slowing of the reaction over time. To 
account for the natural variation in PCR efficiency, the value σE was introduced. 
For both sample sets, this value was varied at 0, 5, 10, and 20%, as the actual 
value is not known. To account for the slowing of product formation, an equation 
developed previously within the laboratory using qPCR data was used. This 
equation was determined to be: Δ𝐸 = 1− 𝑒!!.!"##∗!"!!"∗!!!!   (Equation 6), 
where ΔE is the change in efficiency and Cn-1 is the amount of DNA after n-1 
cycles. Combining the natural variation and the slowing of the reaction as the 
number of cycles increased, the final equation for E was: 
 𝐸 = 𝑁𝑜𝑟𝑚𝑎𝑙 1,𝜎𝐸 − Δ𝐸                            (Equation 7). 
The efficiency of the PCR was assumed to be 1 and normally distributed with a 
standard deviation of σE. This equation was used for E in Equation 5. 
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3.1.2.3   Capillary Electrophoresis (CE):  
This section simulates the DNA travelling through the capillary 
electrophoresis and being detected by the CCD camera (Figure 32). The 
reported value was the observed peak height after 29 cycles of PCR. Stutter, 
background noise, and PCR artifacts were not considered in this model.  
 
Figure 32. Model of Capillary Electrophoresis. 
 
 Prior to calculating the peak heights obtained from the amplified DNA, 
several parameters needed to be defined.  The relative standard deviation (RSD) 
of injecting a sample was set to 0.05. This was determined by examining the 
standard deviation across all targets in Validation 2 (i.e. same sample 
preparation injected multiple times, see Section 2.0). The calibration sensitivity, 
Sl, was also calculated for each locus. To do this, the peak heights of 96 samples 
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run at seven low-template target amounts (i.e. 0.25- 0.008 ng) using Identifiler® 
Plus were used. The theoretical amount of DNA after 29 PCR cycles was 
calculated for each initial target amount using the equation: 𝐶!" =   𝐶! ∗   2!"   (Equation 8), 
where C29 was the amount of DNA after 29 cycles and C0 was the target amount 
of DNA. For each locus, the observed peak heights, in RFU, were plotted against 
C29 and a linear regression was applied to the graph. The slope of the line was 
used as the sensitivity for that locus, with units of RFU/ng. The calibration 
sensitivities for each locus are listed in Table 6. 
Table 6. Calibration sensitivities of capillary electrophoresis for the 15 STR loci. 
Locus 
Calibration 
Sensitivity 
(RFU/ng) 
D8S1179 8.95E-06 
D21S11 7.03E-06 
D7S820 5.34E-06 
CSF1PO 6.23E-06 
D3S1358 8.97E-06 
TH01 9.87E-06 
D13S317 9.01E-06 
D16S539 8.21E-06 
D2S1338 6.47E-06 
D19S433 7.53E-06 
vWA 7.82E-06 
TPOX 6.38E-06 
D18S51 5.95E-06 
D5S818 6.99E-06 
FGA 6.14E-06 
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 The injection variation, σi, was calculated as the sensitivity for a locus 
multiplied by the relative standard deviation of injection (0.05). The peak heights 
obtained after 29 cycles of PCR were calculated for each locus as: 𝑃𝐻 = 𝑁𝑜𝑟𝑚𝑎𝑙(𝑆! , 𝜎𝑖) ∗ 𝐶!",!    (Equation 9), 
where PH is the peak height obtained, Sl is the sensitivity for a given locus, σi is 
the injection variation, and C29,l is the amount of DNA for that locus after 29 
cycles. The distribution of the sensitivity was assumed to be normal, with a 
standard deviation of σi. 
3.1.3   Model Simulations and Analysis 
 The model was run using six targets: 0.25, 0.125, 0.063, 0.031, 0.016, and 
0.008 ng. The first set of experiments, Sample Set 1, involved serially diluting a 
stock solution to achieve the final target concentration that is then amplified. The 
values for the buffer volumes used for each target amount are listed in Table 4. 
These volumes are based on a starting DNA stock concentration of 1000 ng/µL. 
The deviation in PCR efficiency, σE, was varied from 0% to 5%, 10%, and 20%. 
One hundred runs were conducted at each target for each of the four standard 
deviations in PCR efficiency, resulting in 2400 total runs.  
 The same process was used to create samples representative of 
quantifying the samples when no dilution series is required, called Sample Set 2. 
All buffer volumes and pipette variances were set to zero, and the DNA stock 
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value was set to the target DNA amount with a standard deviation of 6%. These 
values are listed in Table 5. The model was run 100 times at each target and σE, 
resulting in 2400 total runs for Sample Set 2.  
The data obtained from each run included:  
• The volume of buffer added at each dilution step if applicable 
• The amount of DNA after each cycle  
• The PCR efficiency for each cycle 
• Peak heights for two alleles per locus for the 15 loci after each cycle 
The information of interest was the peak heights obtained from the last cycle of 
PCR. The data were sorted by experiment, target, and locus. The peak heights of 
the two alleles within a locus were considered as one data set because the 
length of the allele was assumed to have no effect on amplification. This resulted 
in 200 data points per locus. A peak height equivalency value was calculated for 
each data point by dividing that peak height by the largest peak height in the set 
(PHmax). All loci within a target for each experiment were combined and plotted 
as a cumulative histogram. The resulting graphs were fitted with the following 
curve: 𝑦 = 𝑏𝑎𝑠𝑒 +    !"#!!"#$!! !!!"#! !"#$      (Equation 10), 
where the base is the minimum y value, max is the highest y value, the rate is the 
rise rate, and xhalf is the x value at which 𝑦   =    (!"#$  !  !"#)! .60 The spread of each 
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data set was determined by first calculating the x values that marked the bounds 
of the range including 99% of the peak heights. For each data set, Equation 10 
was solved for y= 0.005 and y= 0.995 using the resulting values from the fitted 
curve. The two calculated values were identified as x0.005 and x0.995. The spread 
was calculated by the equation: 𝑆𝑝𝑟𝑒𝑎𝑑   =   𝑥!.!!"   −   𝑥!.!!"   (Equation 11). 
The spreads could then be compared to determine if diluting an extract post-
quantification impacted the peak heights and/or the variation in peak heights. 
3.2 Results 
3.2.1   Analysis of the Model Simulations  
 
 DNA standards used in the laboratory, particularly for validation, are 
commonly prepared using a dilution series. This can result in a propagation of 
error due to the multiple volume transfers; the more dilutions performed, the less 
precise the resulting concentrations. Therefore, determining if a serial dilution 
has an effect on observed peak heights could help improve general laboratory 
practices, and more specifically, the preparation of samples used during 
validation.  
The use of a model to examine this aspect of DNA analysis allowed 
hundred of experiments to be run. Because the exact deviation of PCR efficiency 
is unknown, four values were chosen: 0%, 5%, 10%, and 20%. For each 
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deviation in PCR efficiency, 100 samples were run for both Sample Set 1 and 
Sample Set 2. The obtained peak heights for each run could then be compared 
on a per-target basis between the 8 experiments.  
Overall, it was observed that there was a difference in peak height 
equivalencies between Sample Set 1 and Sample Set 2 (Figure 33). Serial 
dilutions have previously been found to increase error in other analytical fields. 
For example, Hedges performed computer simulations and theoretical analysis to 
assess the effect of serially diluting bacterial suspensions on the number of 
bacteria that grow in a plate. Simulated samples were serially diluted in ten- and 
two-fold steps prior to being cultured. Both dilutions gave similar results; 
therefore, only the 10-fold dilution steps were discussed. Ten plates were 
simulated for each of the following: six 10-fold-dilution steps, seven 10-fold-
dilution steps, and eight 10-fold-dilution steps. Within each set (i.e. six, seven, or 
eight dilution steps), the number of colonies was counted for each plate and 
averaged. The coefficient of variation was calculated, and it was observed that it 
increased as the number of dilution steps increased.68  
Comparing Sample Set 1 to Sample Set 2, it was observed that xhalf was 
consistently lower in Sample Set 1 (i.e. samples prepared using a serial dilution) 
up to σE = 10%. This suggests that the peak heights are less reproducible when 
serial dilutions are used to prepare a sample if the deviation in PCR efficiency is 
less than or equal to 10%. When xhalf was examined for Sample Sets 1 and 2 
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with σE = 20%, there was less of a difference between the data sets, suggesting 
that the large error in PCR efficiency is masking the error obtained via volume 
transfer. 
The spread of the data, calculated as x0.995 – x0.005, was larger for Sample 
Set 1 compared to Sample Set 2 for all experiments except three (Tables 7 and 
8). At 0.125 and 0.031 ng with a deviation in PCR efficiency of 20% as well as at 
0.063 ng with a deviation in PCR efficiency of 10%, the spread was 0.8 for both 
the dilution series and non-dilution series runs. Additionally, a spread could not 
be calculated for the following experiments: Sample Set 1 with a 20% deviation in 
PCR efficiency at 0.008, 0.016, 0.063, and 0.25 ng; and Sample Set 2 with a 
20% deviation in PCR efficiency at 0.063 ng. When Equation 10 was solved for 
y=0.005 for these experiments, the equation returned an error due to taking the 
root of a negative number. It was observed that for these five experiments, the 
base value obtained from the fitted curves was positive, while the majority of 
other base values were negative (Tables 7 and 8). In addition to the changes in 
spread of the data, it was noted that, as the deviation in PCR efficiency 
increased, the difference in spread between Sample Set 1 and Sample Set 2 
decreased. Like the results observed for xhalf, this suggests that if the true 
deviation in PCR efficiency were high enough, it could be the major factor for 
observed peak height differences making the propagation of error caused via 
volume transfer negligible in comparison. 
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Figure 33. Normalized, cumulative histograms of the peak height equivalency for Sample Set 1 
and Sample Set 2 with varied deviations in PCR efficiency (σE) at (A) 0.25, (B) 0.125, (C) 0.063, 
(D) 0.031, (E) 0.016, and (F) 0.008 ng. The histograms were fitted with Equation 10. The value 
σE refers to the deviation in PCR efficiency, described in Equation 7. 
A B 
C D 
E F 
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Table 7. Parameters from fitting the PHE data for 0.25, 0.125, and 0.063 ng of DNA with 
Equation 10, the x0.005 and x0.995, and the spread of the peak heights for Sample Sets 1 and 2 at 
σE 0%, 5%, 10%, and 20%. N/A = not applicable. 
Target 
(ng) 
σE 
(%) 
Sample 
Set Experiment Base Max Rate xhalf x0.005 x0.995 Spread 
0.25 
0 1 Diluted 0.002 1.017 7.93 0.5873 0.3 0.9 0.7 
0 2 Not Diluted -0.006 1.034 10.9 0.704 0.5 0.9 0.5 
5 1 Diluted -0.020 1.040 5.19 0.521 0.25 0.95 0.69 
5 2 Not Diluted -0.003 1.018 8.45 0.6104 0.3 1 0.6 
10 1 Diluted -0.006 1.021 4.40 0.388 0.1 0.9 0.8 
10 2 Not Diluted -0.012 1.019 4.89 0.424 0.18 0.91 0.73 
20 1 Diluted 0.005 1.020 2.59 0.207 N/A 0.9 N/A 
20 2 Not Diluted 0.001 1.017 2.67 0.2114 0.03 0.9 0.8 
0.125 
0 1 Diluted -0.012 1.009 7.03 0.5198 0.29 0.96 0.67 
0 2 Not Diluted -0.005 1.027 10.65 0.6920 0.4 1 0.5 
5 1 Diluted -0.006 1.020 6.38 0.5243 0.3 0.9 0.7 
5 2 Not Diluted -0.007 1.022 7.79 0.6063 0.3 1 0.6 
10 1 Diluted -0.013 1.03 4.05 0.397 0.15 0.91 0.76 
10 2 Not Diluted -0.007 1.018 5.37 0.4612 0.2 0.9 0.7 
20 1 Diluted 0.001 1.033 2.34 0.210 0.0 0.8 0.8 
20 2 Not Diluted -0.002 1.024 2.60 0.221 0.0 0.9 0.8 
0.063 
0 1 Diluted -0.004 1.020 6.34 0.5177 0.2 0.9 0.7 
0 2 Not Diluted -0.005 1.025 11.05 0.7006 0.5 1 0.5 
5 1 Diluted -0.004 1.029 5.65 0.499 0.2 0.9 0.7 
5 2 Not Diluted -0.008 1.024 7.77 0.6002 0.3 0.9 0.6 
10 1 Diluted -0.005 1.02 4.51 0.402 0.1 0.9 0.8 
10 2 Not Diluted -0.002 1.024 4.85 0.438 0.2 0.9 0.8 
20 1 Diluted 0.006 1.022 2.38 0.187 N/A 0.8 N/A 
20 2 Not Diluted 0.008 1.023 2.51 0.209 N/A 0.9 N/A 
 
 
 
 
 
 
 
 
 
69 
 
Table 8. Parameters from fitting the PHE data for 0.031, 0.016, and 0.008 ng of DNA with 
Equation 10, the x0.005 and x0.995, and the spread of the peak heights for Sample Sets 1 and 2 at 
σE 0%, 5%, 10%, and 20%. N/A = not applicable. 
Target 
(ng) 
σE 
(%) 
Sample 
Set Experiment Base Max Rate xhalf x0.005 x0.995 Spread 
0.031 
0 1 Diluted -0.0018 1.023 6.97 0.5775 0.28 0.96 0.68 
0 2 Not Diluted -0.003 1.023 10.86 0.6886 0.4 1 0.5 
5 1 Diluted 0.004 1.017 5.60 0.459 0.1 0.9 0.8 
5 2 Not Diluted -0.012 1.029 7.5 0.596 0.35 0.93 0.59 
10 1 Diluted -0.011 1.019 4.18 0.365 0.13 0.89 0.76 
10 2 Not Diluted -0.010 1.023 4.95 0.4518 0.19 0.93 0.74 
20 1 Diluted -0.001 1.026 2.43 0.207 0.03 0.9 0.8 
20 2 Not Diluted -0.005 1.032 2.36 0.213 0.03 0.9 0.8 
0.016 
0 1 Diluted -0.013 1.014 7.3 0.576 0.33 0.99 0.66 
0 2 Not Diluted -0.005 1.030 10.7 0.6954 0.5 1 0.5 
5 1 Diluted -0.005 1.025 6.31 0.538 0.3 0.9 0.7 
5 2 Not Diluted -0.005 1.025 7.86 0.6156 0.3 1 0.6 
10 1 Diluted -0.007 1.032 4.18 0.414 0.1 0.9 0.8 
10 2 Not Diluted -0.007 1.020 5.00 0.437 0.2 0.9 0.7 
20 1 Diluted 0.010 1.026 2.58 0.223 N/A 0.85 N/A 
20 2 Not Diluted 0.002 1.019 2.69 0.219 0.0 0.9 0.9 
0.008 
0 1 Diluted -0.013 1.005 6.18 0.4608 0.24 0.98 0.74 
0 2 Not Diluted -0.004 1.022 11.15 0.6915 0.5 1.0 0.5 
5 1 Diluted -0.013 1.029 5.24 0.4956 0.23 0.95 0.72 
5 2 Not Diluted -0.012 1.027 7.8 0.609 0.36 0.95 0.58 
10 1 Diluted -0.008 1.019 3.70 0.3322 0.1 0.9 0.8 
10 2 Not Diluted -0.013 1.024 4.80 0.4463 0.19 0.93 0.74 
20 1 Diluted 0.009 1.024 2.28 0.183 N/A 0.9 N/A 
20 2 Not Diluted -0.006 1.024 2.71 0.229 0.04 0.9 0.8 
 
 
Although serially diluting samples has been identified as a source of 
variation in observed peak heights, this only accounts for any inaccuracy in 
volume. While PCR efficiency has been incorporated into the model, other 
studies have indicated that stochastic effects including the synthesis of various 
levels of stutter, differential amplification of alleles, and pre-amplification sample 
processing can affect the results of STR analysis. 9,11,69 Additionally, further 
investigation of the number of DNA copies transferred during the volume transfer 
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and its effect on peak heights would aid in further characterizing the variation 
introduced when samples are serially diluted. Therefore, additions to the current 
model that account for these other stochastic effects would allow for a better 
understanding of the variation in observed peak heights during forensic STR 
analysis.  
 
4.0 Development of a Electrochemical Biosensor for the Detection of DNA 
4.1 Methods 
4.1.1   Materials and Reagents 
 
 The chemicals used were from Fisher Scientific and Sigma-Aldrich, unless 
otherwise noted. All solutions were prepared in deionized water of 18.2 MΩ·cm 
resistivity. The solutions used were: phosphate buffered saline (PBS) pH 7.4; 10 
mM tris(2-carboxyethyl)phosphine (TCEP); 2 mM mercaptohexanol; alumina; 0.5 
M sulfuric acid (H2SO4); 0.01 M potassium chloride (KCl)/ 0.1 M H2SO4; and 0.5 
M potassium hydroxide (KOH). The PBS pH 7.4 was prepared as follows: 2.92 g 
sodium chloride, 0.0690 g sodium phosphate monobasic, 0.071 g sodium 
phosphate dibasic, and 50 mL of 1 M magnesium chloride were added to 25 mL 
deionized water and stirred to dissolve. The pH was adjusted to 7.0-7.2 with 
concentrated sodium hydroxide, after which deionized water was added to bring 
the final volume to 50 mL.61  
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The ssDNA probe ordered from Biosearch Technologies, Inc. (Novato, 
CA) was modified with methylene blue at the 3’ end and with a thiol C6 linker at 
the 5’ end. The sequence of the strand was: 
5’-d Thiol C6 SS-CGGGAAGGGAACAGGACTAAG-Methylene Blue 3’ 
A 200 µM stock solution was prepared in PBS pH 7.4. The sequence of the 
complementary strand ordered from Invitrogen (Grand Island, NY) was: 
c-TPOX: 5’-CTTACTCCTGTTCCCTTCCCG-3’ 
A stock solution of 100 nM c-TPOX was prepared in PBS pH 7.4.  
 For the electrochemical analysis, Dr. Bob’s Electrochemical Cell™ Kit 
purchased from Gamry Instruments (Warminster, PA) was used. This included a 
jacketed cell, a platinum wire counter electrode, and a silver/ silver chloride 
reference electrode submerged in saturated potassium chloride. The salt bridge 
for the reference electrode was filled with PBS pH 7.4. A 3 mm diameter gold 
disk electrode, with a Kel-F body, was purchased from Gamry Instruments.  
4.1.2   Instrumentation and Software 
 All electrochemical measurements were performed using the Series G™ 
750 Potentiostat/Galvanostat/ZRA instrument, using Gamry Framework™ v. 6.11 
for cyclic voltammetry, square wave voltammetry, and linear sweep voltammetry. 
All analysis of the data was performed in Echem Analyst™ v. 6.11. Graphical 
analysis was performed in IGOR Pro v 6.2 (WaveMetrics, Inc., Portland, OR).   
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4.1.3   Developing the Gold-Based Biosensor 
 The method for creating the biosensor, using a SAM of ssDNA, was 
adapted from a protocol by Rowe et al.37 One microliter of 200 µM ssDNA probe 
was reduced with 2 µL of 10 mM tris(2-carboxyethyl) phosphine (TCEP) in the 
dark for one hour at room temperature. A second 2 µL-aliquot of TCEP was 
added and the reaction was allowed to sit in the dark at room temperature for 
another hour. TCEP reduces the thiol and methylene blue moiety on the probe. 
Once the probe had been reduced, it was diluted to a final concentration of 200 
nM with 995 µL PBS pH 7.4.  
 While the probe was being reduced, the gold disk electrode was prepared 
for use. Typically the electrode is cleaned, which can be done both physically, 
through polishing, and electrochemically, through CV or other voltammetric 
techniques. For this experiment, the electrode was polished with alumina mixed 
with water in a figure eight pattern for 3 minutes. It was then submerged in 
deionized water and sonicated for five minutes. The electrode was also 
electrochemically cleaned, first in 0.5 M H2SO4 and then in 0.01 M KCl / 0.1 M 
H2SO4. All electrochemistry was performed using Dr. Bob’s Cell™. For the 
cleaning in 0.5 M H2SO4, an oxidation step was performed by applying +2 V for 5 
seconds to the cell. A reduction step was performed by applying -0.35 V for 10 
seconds. CV was then performed, where the potential was scanned from -0.35 V 
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to +1.5 V for 20 cycles at a rate of 4 Vs-1 and for 4 cycles at a rate of 0.1 Vs-1. 
The second set of cleanings in 0.01 M KCl / 0.1 M H2SO4 were performed at a 
rate of 0.1 Vs-1 for 10 cycles for each of four potential ranges. These ranges 
were: +0.2 V to +0.75 V; +0.2 V to +1.0 V; +0.2 V to +1.25 V; and +0.2 V to +1.5 
V. Having cleaned the electrode, a measurement of the bare gold electrode was 
taken using square wave voltammetry (SWV). The electrode was immersed in 
PBS pH 7.4, and SWV was run from +0.0 V to -0.6 V, with an amplitude of 25 
mV, a frequency of 50 Hz, and a step size of 1 mV.  
 The cleaned electrode was submerged in the 200 nM reduced DNA probe 
and incubated for 1 hour, allowing the probe to chemisorb to the electrode and 
form the SAM. This was achieved through the formation of a sulfur-gold covalent 
bond between the reduced thiol and the surface of the electrode. The electrode 
was then incubated in 2 mM mercaptohexanol overnight which helps prevent the 
non-covalent bonding of the DNA to the electrode surface and stabilizes the 
probe in an upright position.45 This is depicted in Figure 34.  
 
Figure 34. Mercaptohexanol (MCH) interacts with the surface of the electrode to prevent non-
specific binding of the DNA probe and assists in the formation of a stable, up-right SAM. 
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 When removed from the mercaptohexanol, the electrode was rinsed with 
deionized water for one minute. The electrode was immersed in PBS pH 7.4 in 
the electrochemical cell for 10 minutes, and then SWV was performed on the 
SAM. SWV was run from +0.0 V to -0.6 V, with an amplitude of 25 mV, a 
frequency of 50 Hz, and a step size of 1 mV. A peak was expected at 
approximately – 0.35 V.37 The peak represents the current flow due to the 
interaction of the redox indicator, in this case methylene blue, with the surface of 
the electrode and the transfer of electrons that occurs.37 This mechanism is 
presented in Figure 35A. 
 
Figure 35. Schematic of the redox indicator’s interactions with the electrode surface in a 
biosensor. When the DNA probe has been chemisorbed to the electrode surface, the redox 
indicator is able transfer electrons (e-) and, therefore, a current is produced (A). After the 
hybridization of the target DNA strand to the probe, the formation of the double stranded DNA 
prevents the indicator from interacting with the electrode’s surface and causes a decrease in 
current.  
The electrode was then incubated in 100 nM c-TPOX, the complementary 
strand of the DNA probe, for two hours. During the incubation, the 
complementary strand was able to hybridize to the probe. SWV was performed 
again, on the newly formed hybridized product, with the same parameters used 
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for the SAM. If hybridization was successful, a decrease in the current is 
expected.37 This is due to the hybridization of the target preventing the redox 
indicator from interacting with the electrode surface, and therefore no electrons 
are transferred (Figure 35B). Again a peak was expected at approximately – 0.35 
V.37 The change in peak height between the SAM and the post-hybridization 
analyses can then be related to the concentration of the sample. 
In addition to detecting the ssDNA, it was of interest to examine the effect 
of MCH on the measured current. Therefore, the cleaning of the electrode was 
repeated and SWV was performed on the bare gold electrode using the 
previously defined parameters. The electrode was then incubated in MCH 
overnight, and SWV was performed again. The voltammogram was compared to 
the bare gold and recognition layer voltammograms. 
4.1.4   Analyzing Square Wave Voltammograms  
 All analysis was performed using Echem Analyst™ v. 6.11. A linear 
baseline was set using the linear fit available in Echem Analyst™, and the peak 
heights for the SAM and post-hybridization layer were measured to the baseline, 
in nanoamperes (nA). The percent change in peak height was calculated by the 
equation:  %  𝑐ℎ𝑎𝑛𝑔𝑒 = !""!!"!" ∗ 100%  (Equation 12), 
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where PHH is the height of the post-hybridization layer peak and SH is the height 
of the SAM peak.37 
4.1.5   Desorbing DNA from the Gold Disk Electrode 
 To reuse the electrode, the DNA probe was electrochemically desorbed 
from the gold disk electrode. To accomplish this, the electrode was immersed in 
0.5 M KOH, and LSV was performed for 25 cycles from -0.25 V to -1.3 V. Peaks 
were expected at approximately -1020 mV, due to mercaptohexanol, and at -560 
mV, due to the DNA probe desorption.54 As the number of cycles increased, it 
was expected that the strength of the peaks would decrease as the molecules 
were desorbed from the electrode.  
4.1.6   Controlling the Formation of the Self-Assembled Monolayer 
 After confirming that a DNA probe could be adsorbed to the gold disk 
electrode, hybridized to a complementary strand, detected through 
electrochemical techniques, and then desorbed, it was of interest to examine the 
reproducibility of forming the SAM. To do this, the protocol used to first develop 
the biosensor was used; however, the incubation time in the 200 nM solution of 
reduced DNA probe was varied from 1 hour to 15 minutes, 30 minutes, 6 hours, 
and overnight. Because the focus of the experiments was the generation of the 
SAM, the hybridization step was not performed. Three experiments were 
performed at each time point. For each set of time points, the experiments were 
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performed in a random order to ensure that there was not an increase in signal 
due to the build up of DNA on the electrode surface over time. As in the previous 
experiment, the height of the observed peaks for the SAMs was determined. A 
comparison was made between the time points as well as within a single time 
point to examine the change in the amount of DNA chemisorbed over time and 
the reproducibility of forming the SAM. Student’s t-test was performed on 
adjacent pairs of time points to determine if there was a significant difference 
between them. The critical p-value was set to 0.05, with anything below this 
indicating a significant difference. This resulted in four comparisons: 15 to 30 
minutes; 30 minutes to 1 hour; 1 hour to 6 hours; and 6 hours to overnight. The 
average and standard deviation were also calculated for the runs within each of 
the 5 time points. The averages were used to calculate Delta I, or change in 
current, in nA. This was calculated as the difference in peak height between a 
given time point and the time point immediately preceding it.    
4.2 Results 
4.2.1 Developing the Biosensor 
 
To create the biosensor, a SAM was formed on the surface of the 
electrode using a 200 nM solution of a ssDNA probe. The formation of the 
monolayer was confirmed by comparing square wave voltammograms of the 
bare gold electrode, the MCH layer, and the SAM, using the same instrument 
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parameters for all analyses. The three voltammograms, plotted on the same axis, 
are presented in Figure 36. No distinct peak was identified in the bare gold 
voltammogram by the Echem Analyst software. After the hybridization of the 
DNA probe, a peak was detected at -272.0 mV, with a peak height of 458.9 nA 
when a linear baseline was set in Echem Analyst. Rowe et al. reported that the 
DNA peak is at -350 mV; however, this can be affected by slight changes in the 
pH of the PBS buffer.37 Additionally, it was observed that when the electrode was 
exposed to only MCH, the measured current was lower than that of the bare gold 
and the SAM. Therefore, the large difference in current between the bare gold 
and the SAM was due to the incorporation of MCH into the SAM, and the current 
measured for the SAM was due to the chemisorption of the DNA probe to the 
electrode. 
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Figure 36. Comparison of the bare gold SWV voltammogram (- - -), the SAM SWV 
voltammogram (—), and the MCH SWV voltammogram (- - -). 
 
Having confirmed that a SAM was formed, the next step was to hybridize 
a complementary ssDNA molecule to the probe. After incubating the biosensor in 
the target strand, SWV was performed again using the same parameters used 
for the bare gold and SAM analyses. The SAM voltammogram and the post-
hybridization voltammogram are presented on the same axis in Figure 37. The 
height of the peak observed in the post-hybridization voltammogram was 273.1 
nA. The percent change between the SAM and the post-hybridization 
voltammograms for this experiment was -40.49%, which is slightly lower than the 
results obtained by Rowe et al., who reported a percent change of approximately 
60%.37 This decrease in peak height confirmed that the complementary strand 
hybridized with the probe, because the methylene blue on the hybridized DNA 
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probe was no longer able to interact with the electrode surface and, therefore, 
could not conduct as much current.  
 
 
Figure 37. Square wave voltammograms of the SAM (—) and the post-hybridization layer (- - -). 
The peak heights were measured to the baseline (- - -) and are listed at the apex for each 
analysis. 
 
4.2.2   Desorbing DNA from the Gold Disk Electrode 
 To be able to reuse the gold disk electrode, the chemisorbed DNA probe 
was desorbed from the electrode. When LSV was performed, a broad peak at 
approximately -600 mV was observed and indicated the presence of the DNA. A 
second peak was observed at -1120 mV, indicating the presence of 
mercaptohexanol. These values were slightly different from the values of -560 ± 
30 mV for DNA and -1020 ± 10 mV reported by Sánchez-Pomales et al.54 This 
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could be due to a slight difference in the concentration between the potassium 
hydroxide used for these experiments and that used by Sánchez-Pomales et al, 
as Dong and Li have demonstrated that changes in ionic strength of the buffer 
can change the potentials.43 Desorption was visualized by a decrease in height of 
the DNA and mercaptohexanol peaks as the number of cycles increased (Figure 
38).  LSV was performed until the peaks plateaued. Desorption of the DNA was 
confirmed by comparing the bare gold electrode measurements performed in 
PBS pH 7.4 during the chemisorption process of the different time point 
experiments (Figure 39). Fifteen bare gold voltammograms were used for 
comparison. Visual inspection demonstrates that the shape of the curve obtained 
is very reproducible between experiments, confirming that DNA was desorbed.  
 
Figure 38. Linear sweep voltammograms of the desorption of DNA from the gold disk electrode 
for two separate desorptions, identified by the dashed and solid lines. The runs shown are cycles 
1, 5, 10, 15, 20, and 25, with the first and last runs labeled. The regions that represent the DNA 
peak and the MCH peak are also labeled. 
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Figure 39. Square wave voltammograms of 15 analyses of the bare gold electrode in PBS pH 7.4 
measured during the time point studies, which were used to confirm the desorption of the SAM.  
 
4.2.3   Controlling the Formation of the Self-Assembled Monolayer 
 A time study was conducted to determine to what extent the amount of 
DNA chemisorbed to the surface of the gold electrode could be controlled and 
how reproducible the formation of the SAM is. The three peak heights obtained 
from each run at the five time points (grey symbols) were plotted, in addition to 
the average (solid black symbols) ± 1 standard deviation, and are presented in 
Figure 40. The data indicated that the peak heights increased as the incubation 
time in the probe solution increased from 30 minutes to 1 hour. This increase in 
current, representative of an increase in surface coverage, is expected for 
chemisorption processes and suggests that maximal surface coverage can be 
obtained between 30 minutes and 1 hour.  
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When the incubation was increased to six hours and overnight, a slight 
decrease in the average signal was observed. This plateauing of surface 
coverage was also observed by Campuzano et al., but at a later time point.70 
They saw no significant increase in surface coverage after a 20-hour incubation 
in a 40 mM alkanethiol solution. The differences between these results and those 
observed by Campuzano et al. could potentially be due to the differences in 
concentration of the probe solutions or the different type of recognition molecule. 
Sánchez-Pomales et al. noted a sharp increase in the surface coverage with the 
increase in immobilization time, as was suggested in this time study by the sharp 
increase in the measured current between the 30 minutes and 1 hour 
incubations; however, they observed a slowing in the increase in coverage after 
15 hours.54 This differed from the slowing, and slight decrease, observed after 1 
hour in this time-dependence study.  
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Figure 40.  Average current (peak height) ± 1 standard deviation plotted versus time for the five 
time points examined to determine the controllability of the SAM formation. The solid circle 
indicates the average peak height and the open grey circles indicate the individual runs. The 
insets indicate the difference in current, Delta I, and the p-value from Student’s t-test for adjacent 
time points.  
 
 Further analysis of the results included calculating Delta I and performing 
Student’s t-test on adjacent time points (Insets on Figure 40). From this, it was 
determined that there was a significant difference between the 30 minute and 1 
hour incubations (p<0.05). The largest Delta I was observed between these time 
points as well, at 204.5 nA. Additionally, there appeared to be a maximum 
amount of DNA that can be chemisorbed to the electrode surface, evidenced by 
the plateauing of the measured peak heights for incubations longer than one 
hour. Therefore, for the practical implementation of an electrochemical biosensor, 
1 hour was deemed the optimal time to incubate the electrode in a 200 nM probe 
solution, and this is consistent with the incubation time used by Rowe et al.37  
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5.0 Conclusions 
 This research aimed to characterize the variability in forensic DNA 
analysis; specifically the uncertainty in the analytical measurement that was 
caused by normal alterations in the laboratory including changing capillaries, 
performing different injections and amplifications, and using different kit lots, as 
well as the variability caused by the use of a dilution series was examined. 
Additionally, it was of interest to explore the possibility of using a biosensor as a 
direct method for the quantification of DNA to potentially decrease the variability 
in DNA analysis.  
 Of the parameters evaluated, it was observed that both different capillary 
lots and different amplifications introduced additional variability compared to 
different injections. Further, differences in kit lots introduced added variability with 
respect to stutter and drop-out when compared to the multiple amplifications, 
while the peak heights and peak height ratios between the two parameters were 
comparable. While there was a difference between the different amplifications 
and different kit lots, further research on the effect of different kit lots would be of 
great value in forensic DNA analysis, as only a small sample size was evaluated 
for drop-out. Based on the results obtained, current validation practices ideally 
would include running samples on multiple capillary lots and amplifying samples 
multiple times using multiple kit lots.  
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 Through the use of an in silico dynamic model of the DNA analysis 
process, serially diluting validation samples post-quantification also had an 
impact on the variability of observed peak heights. As the estimated deviation in 
PCR efficiency increased to 20%, effects of the post-quantification dilution 
decreased when compared to samples that were not diluted after quantification. 
However, this model did not include many of the sampling and stochastic effects, 
such as DNA being adsorbed to a tube, PCR artifact generation during 
amplification, and sampling effects. Therefore, the full extent to which serially 
diluting a sample influences the observed results cannot be determined without 
expansion of the dynamic model.  
 Lastly, given the error associated with PCR, and consequently qPCR, a 
direct measurement technique for DNA was investigated. The development of a 
biosensor was successful, with the formation of a self-assembled monolayer of 
ssDNA probe on the surface of a gold disk electrode, which could be detected 
using SWV. The probe was able to hybridize to a target strand, and the expected 
decrease in current, due to the redox indicator no longer being able to interact 
with the surface of the electrode, was observed. Further, investigation into the 
formation of the SAM demonstrated that, by changing the incubation time of the 
electrode in the reduced probe solution, the amount of DNA chemisorbed on the 
electrode surface could be controlled. After 1 hour, no additional current increase 
was observed, and therefore, this was deemed the optimal incubation time. The 
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ability to form the SAM and detect a hybridized product, as well as control the 
formation of the SAM, indicates that a biosensor is a promising technique for the 
direct measurement of the concentration of forensic DNA samples.  
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